Does Dr. GUSTAVO DIAZ-MERCADO have financial conflicts of interest?

Dr. GUSTAVO DIAZ-MERCADO (M.D.) has received a total of $242 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $242 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. GUSTAVO DIAZ-MERCADO?

According to CMS Open Payments data, Dr. GUSTAVO DIAZ-MERCADO received funding from FISHER & PAYKEL HEALTHCARE ($130), BOSTON SCIENTIFIC CORPORATION ($77), and PACIRA PHARMACEUTICALS INCORPORATED ($36).

Does Dr. GUSTAVO DIAZ-MERCADO receive research grants or speaking fees?

Dr. GUSTAVO DIAZ-MERCADO has received $242 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. GUSTAVO DIAZ-MERCADO

M.D.Real-Time Hydrated

Specialty: Anesthesiology

Practice Location: KENNER, LA 70065

NPI Number: 1073928768

LIFETIME INDUSTRY VALUE

$242

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. DIAZ-MERCADO is a verified Anesthesiology practitioner based in KENNER, LA.

Between 2021 and 2025, Dr. DIAZ-MERCADO had an overall industry promotional and research financial footprint of $242 as recorded in the federal CMS Open Payments database.

$242 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. DIAZ-MERCADO's primary funding source is FISHER & PAYKEL HEALTHCARE, which accounts for $130 (representing 53.6% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

FISHER & PAYKEL HEALTHCARE

Rank 1

$130

53.6%

BOSTON SCIENTIFIC CORPORATION

Rank 2

$77

31.7%

PACIRA PHARMACEUTICALS INCORPORATED

Rank 3

$36

14.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.